Pharvaris BV

Healthcare · Biotechnology

31.20$ +0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Pharvaris BV (PHVS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 329 million EUR. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PHVS
Line item	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	1.2	1.2	1.2	1.2	1.4	1.4	1.4	1.4	5.1	5.1	5.1	21	25	25	43	101	244	230	223	212	201	207	203	168	148	190	169	399	378	352	313	291	248	210	339	301	260	329
Current Assets	1.2	1.2	1.2	1.2	1.4	1.4	1.4	1.4	5.1	5.1	5.1	21	20	25	43	101	244	229	223	212	201	206	203	167	147	189	169	398	377	351	312	289	246	208	337	299	258	327
Cash	1.2	1.2	1.2	1.2	1.3	1.3	1.3	1.3	5.1	5.1	5.1	20	-20	25	42	99	238	224	219	209	195	201	198	162	135	179	158	391	368	344	305	281	236	200	329	292	247	318
Cash & Short-Term Investments	1.2	1.2	1.2	1.2	1.3	1.3	1.3	1.3	5.1	5.1	5.1	20	20	25	42	99	238	224	219	209	195	201	198	162	135	179	158	–	368	344	305	–	236	200	329	–	247	318
Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.6	0.6	0.6	0.7	0.6	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.3	–	0.8	1.6	2.7	–	2.6	2.6	2.9	–	5.0	5.3
Inventory	–	–	–	–	–	–	–	–	–	–	–	–	-0.6	0.0	–	0.5	0.5	4.2	3.4	1.5	4.8	4.0	3.6	4.0	11	8.5	9.0	–	7.3	0.0	–	–	–	–	–	–	–	–
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	0.0	–	–	–	0.0	0.1	0.4	0.4	0.4	0.3	0.4	0.4	0.6	–	–	0.5	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.5	0.5	0.5	1.9	1.3	1.3	4.4	5.3	8.5	7.5	7.7	7.1	10	16	18	18	19	16	16	15	18	19	16	24	23	25	27	30	23	28
Current Liabilities	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.5	0.5	0.5	1.9	1.3	1.3	4.4	5.3	8.5	7.3	7.5	7.0	10	16	18	18	18	16	16	15	18	19	16	23	22	25	26	30	23	27
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2	–	0.1	0.1	0.1	–	0.2	0.2	0.1	–	0.2	0.2
Accounts Payable	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.2	2.7	0.8	3.9	2.9	3.4	2.1	2.9	3.7	6.4	6.0	7.4	4.6	3.6	2.9	5.6	3.0	4.2	4.6	4.2	4.9	2.5	5.1	2.7	2.8
Shareholders' Equity	1.2	1.2	1.2	1.2	1.2	1.2	1.2	1.2	4.7	4.7	4.7	19	19	24	39	96	236	222	215	205	191	191	185	149	129	174	153	384	359	333	297	268	225	184	312	271	236	301
Retained Earnings	-1.5	-1.5	-1.5	-1.5	-2.6	-2.6	-2.6	-2.6	-4.6	-4.6	-4.6	-18	-11	-11	-34	-44	-51	-66	-75	-88	-104	-116	-125	-164	-187	-209	-233	-266	-294	-325	-367	-402	-449	-495	-532	-580	-620	-669
Shares Outstanding	–	–	–	–	32	32	32	32	32	32	32	32	32	32	32	9.1	32	33	33	33	33	34	34	34	34	35	41	52	54	54	54	54	55	55	62	65	65	68

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings